I'rom Group Co

I'rom Group Co EBIT Margin

Delisted

The EBIT Margin (Operating Margin) of I'rom Group Co (2372.T) as of Oct 9, 2026 is 6.39 %. In the previous year, EBIT Margin (Operating Margin) was 19.83 % — a change of -67.76% (lower).

EBIT Margin

6.39 %

YoY

-67.76%

Last updated:

EBIT Margin (Operating Margin) of I'rom Group Co is 2024 6.39 % . EBIT Margin (Operating Margin) of I'rom Group Co was 2023 19.83 % . It decreases by -67.76% lower compared to the previous year.

I'rom Group Co's operating (EBIT) margin stands at 6.4%, down from 11.4% several years earlier.

The I'rom Group Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2017
4.34 JPY
Jan 1, 2018
12.11 JPY
Jan 1, 2019
11.52 JPY
Jan 1, 2020
11.39 JPY
Jan 1, 2021
8.28 JPY
Jan 1, 2022
17.61 JPY
Jan 1, 2023
19.83 JPY
Jan 1, 2024
6.39 JPY
The I'rom Group Co EBIT Margin history
YEAREBIT MarginYoY
6.39 %-67.76%
19.83 %+12.59%
17.61 %+112.84%
8.28 %-27.37%
11.39 %-1.12%
11.52 %-4.84%
12.11 %+179.33%
4.34 %-137.16%
-11.67 %-37.52%
-18.67 %+86.33%
-10.02 %-18,308.79%
0.06 %-240.06%
-0.04 %-260.29%
0.02 %-313.02%
-0.01 %-392.33%
0.00-121.53%
-0.02 %-78.81%
-0.09 %-610.70%
0.02 %-84.62%
0.11 %—
Access this data via the Eulerpool API
Get Free API Key

I'rom Group Co Stock analysis

What does I'rom Group Co do? I'rom Group Co. Ltd is a Japanese company specialized in medical services. It was founded in April 2007 and is headquartered in Tokyo, Japan. The company has become a significant player in the medical service sector in Japan within a few years. Its business model focuses on medical services and the sale of medical products, specifically in the areas of Life-Science and Clinical Research. I'rom offers support in clinical studies, distributes medications and medical devices, and provides CRM services. The company is divided into different divisions that offer various specialized products and services such as clinical research services, medical development services, corporate staffing services, and CRM services. I'rom also offers a wide range of medical products, mainly targeting the Japanese market. In conclusion, I'rom Group Co. Ltd is a leading company in the field of medical services in Japan, providing integrated support in product development and marketing for the life science and healthcare industries. I'rom Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about I'rom Group Co stock

EBIT Margin (Operating Margin) of I'rom Group Co is 6.39 % in 2024.

EBIT Margin (Operating Margin) of I'rom Group Co changed from 19.83 % to 6.39 %, representing a -67.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) I'rom Group Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s I'rom Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API
Get Free API Key

Margins — I'rom Group Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — I'rom Group Co